NeuroVive Pharmaceutical AB: NeuroVive: Year-End Report 1 Jan. 2013 Till 31 Dec. 2013
Regulatory News:
NeuroVive Pharmaceutical (STO:NVP)
NeuroVive consolidates positioning as leading mitochondrial medicine company
Help employers find you! Check out all the jobs and post your resume.